Citation Impact
Citing Papers
Patterns of Gene Expression and Copy-Number Alterations in von-Hippel Lindau Disease-Associated and Sporadic Clear Cell Carcinoma of the Kidney
2009 StandoutNobel
Genetic and Functional Studies Implicate HIF1 α as a 14q Kidney Cancer Suppressor Gene
2011 StandoutNobel
Gene expression profiling in a renal cell carcinoma cell line: dissecting VHL and hypoxia-dependent pathways.
2003 StandoutNobel
Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: Developmental culling and cancer
2005 StandoutNobel
Capture‐C reveals preformed chromatin interactions between HIF ‐binding sites and distant promoters
2016 StandoutNobel
Treatment of kidney cancer
2009 StandoutNobel
Loss of Hypoxia-Inducible Factor Prolyl Hydroxylase Activity in Cardiomyocytes Phenocopies Ischemic Cardiomyopathy
2010 StandoutNobel
Contrasting Properties of Hypoxia-Inducible Factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-Associated Renal Cell Carcinoma
2005 StandoutNobel
Cell type-selective secretome profiling in vivo
2020 StandoutNobel
A common founder for the 35delG GJB2gene mutation in connexin 26 hearing impairment
2001
Germline mutations in the von Hippel-Lindau (VHL) gene in patients from Poland: disease presentation in patients with deletions of the entire VHL gene
2002
Progressive hearing loss, and recurrent sudden sensorineural hearing loss associated with GJB2 mutations – phenotypic spectrum and frequencies of GJB2 mutations in Austria
2002
pVHL Acts as an Adaptor to Promote the Inhibitory Phosphorylation of the NF-κB Agonist Card9 by CK2
2007 StandoutNobel
The von Hippel–Lindau tumour suppressor protein: O2 sensing and cancer
2008 StandoutNobel
Newborn Hearing Screening — A Silent Revolution
2006 Standout
The von Hippel–Lindau Tumor Suppressor Gene
2001 StandoutNobel
Targeting HIF2 in Clear Cell Renal Cell Carcinoma
2016 StandoutNobel
Hereditary Kidney Cancer Syndromes
2013
Structural and Functional Diversity of Connexin Genes in the Mouse and Human Genome
2002 Standout
New Insights into the Biology of Renal Cell Carcinoma
2011 StandoutNobel
Hypoxia and Inflammation
2011 Standout
A genotype-phenotype correlation for GJB2 (connexin 26) deafness
2004
The von Hippel-Lindau Gene, Kidney Cancer, and Oxygen Sensing
2003 StandoutNobel
Molecular genetics of hearing impairment due to mutations in gap junction genes encoding beta connexins
2000
How oxygen makes its presence felt: Figure 1.
2002 StandoutNobel
Sensorineural hearing loss in children
2005 Standout
von Hippel-Lindau disease
2003 Standout
A Deletion Involving the Connexin 30 Gene in Nonsyndromic Hearing Impairment
2002
HIF-1α Is Essential for Myeloid Cell-Mediated Inflammation
2003 Standout
VHL loss actuates a HIF-independent senescence programme mediated by Rb and p400
2008 StandoutNobel
The VHL/HIF axis in clear cell renal carcinoma
2012 StandoutNobel
Fine analysis of the short arm of chromosome 1 in sporadic and familial pheochromocytoma
2003
VHL and Kidney Cancer
2003 StandoutNobel
Oxygen Sensing by Metazoans: The Central Role of the HIF Hydroxylase Pathway
2008 StandoutNobel
Regulation of Metabolism by Hypoxia-Inducible Factor 1
2011 StandoutNobel
Renal cell carcinoma
2017 Standout
HIF activation identifies early lesions in VHL kidneys
2002 StandoutNobel
Oxygen homeostasis
2009 StandoutNobel
Central nervous system hemangioblastomas, endolymphatic sac tumors, and von Hippel-Lindau disease
2000
The kinesin KIF1Bβ acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor
2008 StandoutNobel
An intact NEDD8 pathway is required for Cullin‐dependent ubiquitylation in mammalian cells
2002 StandoutNobel
Identification of an elaborate complex mediating postsynaptic inhibition
2016 Science
von Hippel-Lindau Disease
2006 StandoutNobel
Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor
2002 StandoutNobel
Chromone: A Valid Scaffold in Medicinal Chemistry
2014 Standout
Kinase requirements in human cells: III. Altered kinase requirements inVHL−/− cancer cells detected in a pilot synthetic lethal screen
2008 StandoutNobel
The von Hippel-Lindau Tumor Suppressor Gene
2020
Molecular Genetics of Hearing Loss
2001
Structural characterization of the cyclin-dependent protein kinase family
2013
Clinical Practice Guideline: Sudden Hearing Loss (Update)
2019 Standout
Molecular pathogenesis of the von Hippel-Lindau hereditary cancer syndrome: implications for oxygen sensing.
2001 StandoutNobel
Dysregulation of the TSC-mTOR pathway in human disease
2004 Standout
Diverse Effects of Mutations in Exon II of the von Hippel-Lindau (VHL) Tumor Suppressor Gene on the Interaction of pVHL with the Cytosolic Chaperonin and pVHL-Dependent Ubiquitin Ligase Activity
2002 StandoutNobel
Genetics of Sensory Mechanotransduction
2002 StandoutNobel
Works of Roberta Polli being referenced
Somatic mosaicism in von Hippel-Lindau disease
2000
Molecular Genetics Applied to Clinical Practice: The Cx26 Hearing Impairment
1999
The CDKL5 disorder is an independent clinical entity associated with early-onset encephalopathy
2012
Cx26 deafness: mutation analysis and clinical variability
1999